The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Ubrolexin intramammary suspension for lactating dairy cows

200 mg/100,000 IU per syringe Intramammary suspension

Boehringer Ingelheim Vetmedica GmbHVPA10454/016/001

Main Information

Trade NameUbrolexin intramammary suspension for lactating dairy cows
Active SubstancesCefalexin monohydrate
Kanamycin monosulphate
Strength200 mg/100,000 IU per syringe
Dosage FormIntramammary suspension
Licence HolderBoehringer Ingelheim Vetmedica GmbH
Licence NumberVPA10454/016/001

Group Information

ATC CodeQJ51RD01 cefalexin, combinations with other antibacterials
Therapeutic ClassAntibacterial


Licence Issued26/10/2007
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back